Medication Regimen Complexity Index Prediction of Adverse Drug Reaction-Related Hospital Admissions.


Journal

The Annals of pharmacotherapy
ISSN: 1542-6270
Titre abrégé: Ann Pharmacother
Pays: United States
ID NLM: 9203131

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 1 5 2020
medline: 1 1 2021
entrez: 1 5 2020
Statut: ppublish

Résumé

The relationship between the medication regimen complexity index (MRCI) and adverse drug reaction (ADR)-related hospital admissions has not yet specifically been investigated. To evaluate the MRCI and compare with medication count for prediction of ADR-related hospital admissions in older patients. This was a retrospective analysis of a prospectively collected convenience sample of 768 unplanned medical admissions of Australians aged 65 years old and older. The sample consisted of 115 (15.0%) ADR-related unplanned hospital admissions and 653 (85.0%) non-ADR-related unplanned medical admissions. The MRCI score was calculated from the medical records and analyzed to predict ADR-related hospital admissions. The cohort had a median age of 81 years, 5 comorbidities, and 11 medications, with a slight majority of women. The MRCI score was not significantly different in patients who had ADR-related admissions compared with other medical admissions-38.5 versus 34.0, respectively; Wilcoxon Rank Sum test The MRCI score did not discriminate between ADR-related admissions and other medical admissions despite taking time to calculate with potential for inconsistent application. Medication count is more readily applicable with marginally greater relevance in this cohort; however, both measures do not appear to be useful when used alone for clinicians to identify patients at risk of ADRs.

Sections du résumé

BACKGROUND
The relationship between the medication regimen complexity index (MRCI) and adverse drug reaction (ADR)-related hospital admissions has not yet specifically been investigated.
OBJECTIVE
To evaluate the MRCI and compare with medication count for prediction of ADR-related hospital admissions in older patients.
METHODS
This was a retrospective analysis of a prospectively collected convenience sample of 768 unplanned medical admissions of Australians aged 65 years old and older. The sample consisted of 115 (15.0%) ADR-related unplanned hospital admissions and 653 (85.0%) non-ADR-related unplanned medical admissions. The MRCI score was calculated from the medical records and analyzed to predict ADR-related hospital admissions.
RESULTS
The cohort had a median age of 81 years, 5 comorbidities, and 11 medications, with a slight majority of women. The MRCI score was not significantly different in patients who had ADR-related admissions compared with other medical admissions-38.5 versus 34.0, respectively; Wilcoxon Rank Sum test
CONCLUSION AND RELEVANCE
The MRCI score did not discriminate between ADR-related admissions and other medical admissions despite taking time to calculate with potential for inconsistent application. Medication count is more readily applicable with marginally greater relevance in this cohort; however, both measures do not appear to be useful when used alone for clinicians to identify patients at risk of ADRs.

Identifiants

pubmed: 32349531
doi: 10.1177/1060028020919188
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

996-1000

Auteurs

Colin M Curtain (CM)

University of Tasmania, Hobart, Tasmania, Australia.

Jie Yi Chang (JY)

University of Tasmania, Hobart, Tasmania, Australia.

Justin Cousins (J)

University of Tasmania, Hobart, Tasmania, Australia.

Nibu Parameswaran Nair (N)

University of Tasmania, Hobart, Tasmania, Australia.

Bonnie Bereznicki (B)

University of Tasmania, Hobart, Tasmania, Australia.

Luke Bereznicki (L)

University of Tasmania, Hobart, Tasmania, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH